# Treatment Intensification With Temozolomide in Adults With a Glioblastoma

> **NCT03663725** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Centre Oscar Lambret** · enrollment: 486 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** Intensified protocol
- **DRUG:** Stupp protocol

## Key facts

- **NCT ID:** NCT03663725
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-03-13
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 486 (ESTIMATED)
- **Last updated:** 2026-03-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03663725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03663725, "Treatment Intensification With Temozolomide in Adults With a Glioblastoma". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03663725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*